Marketing-authorisation holder · United States
Nephron
3 medicines in 1 country, as authorisation holder.
Group structure
Part of
NephronPharmaceutical groupOther companies in the group
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALBUTEROL SULFATE; IPRATROPIUM BROMIDE0.5mg; 0.017% · Solution | Salbutamol, Ipratropium bromide | United States | Marketed | 2007 |
| BETA-21% · Solution | Isoetharine | United States | Not marketed | 1981 |
| LEVALBUTEROL HYDROCHLORIDE0.0103% base | 0.021% base | 0.042% base | 0.25% base · Solution | Levalbuterol | United States | Marketed | 2008 |